- Yamanouchi buys Fujisawa for $7.64bn
- Tanabe, Taisho terminate merger agreement
- Teijin's med/pharma group merges with Kyorin; withdrawn
- GlaxoSmithKline to sell Yamanouchi's Vesicare in US
- Yamanouchi to co-promote Parke-Davis'atorvastatin in Japan
- Yamanouchi, Searle co-develop and co-market celecoxib in Japa
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.